OR2C1 Antibody

What is OR2C1 and what biological functions does it serve?

OR2C1 (Olfactory receptor 2C1) is a member of the olfactory receptor family, which are G-protein-coupled receptors (GPCRs) involved in olfactory signaling. Also known by alternative names like OLFmf3, Olfactory receptor 2C2, Olfactory receptor OR16-1, and Olfactory receptor OR16-2, this protein functions primarily in the detection of specific odors .

OR2C1 is activated by binding organosulfur odorants with thioether groups such as (methylthio)methanetiol (MTMT) and also binds acetophenone and benzaldehyde. Upon odorant binding, the receptor activates G proteins that subsequently activate adenylyl cyclase, propagating the olfactory signal . Beyond basic olfaction, this receptor may play a role in the molecular processes underlying fasciculation and targeting of olfactory axons .

What applications are OR2C1 antibodies typically used for in research?

OR2C1 antibodies are commonly used in several key laboratory applications:

• Western Blot (WB): Used to detect and quantify OR2C1 protein in tissue or cell lysates, with recommended dilutions ranging from 1:500 to 1:2000 .

• Immunofluorescence (IF): Used to visualize OR2C1 localization within cells or tissues, with typical dilutions between 1:100 and 1:500 .

• ELISA: Used for quantitative detection of OR2C1 in solution samples, often at higher dilutions around 1:20000 .

• Immunocytochemistry (ICC): Used to detect the protein in cultured cells .

These applications allow researchers to study OR2C1 expression, localization, and potential interactions in various experimental contexts.

What are the optimal storage conditions for OR2C1 antibodies?

For optimal performance and longevity, OR2C1 antibodies should be stored at -20°C for up to one year from the date of receipt . For short-term storage and frequent use, antibodies can be kept at 4°C for up to one month . It's crucial to avoid repeated freeze-thaw cycles as these can degrade antibody quality and performance .

Most commercial OR2C1 antibodies are supplied in a formulation containing PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide . This formulation helps maintain antibody stability during storage. If small volumes of antibody become entrapped in the seal of the product vial during shipment and storage, a brief centrifugation on a tabletop centrifuge may be necessary to dislodge any liquid in the container's cap .

What species reactivity can be expected from commercially available OR2C1 antibodies?

Most commercial OR2C1 polyclonal antibodies demonstrate cross-reactivity with multiple species. Based on the available data, rabbit polyclonal OR2C1 antibodies typically react with human, mouse, and rat samples . This multi-species reactivity is particularly valuable for comparative studies across different model organisms.

When selecting an antibody for your research, it's important to verify the specific reactivity claims for each product, as some antibodies may have been validated more extensively in certain species over others. The cross-reactivity is largely due to the high degree of conservation in the immunogen region (amino acids 241-290) across these species .

What are the critical considerations when designing experiments to validate OR2C1 antibody specificity?

Validating antibody specificity is crucial for ensuring reliable results. For OR2C1 antibodies, consider the following comprehensive validation strategy:

• Positive and negative controls: Use tissues or cell lines with known OR2C1 expression levels. Olfactory epithelium should show positive staining, while certain non-olfactory tissues can serve as negative controls.

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide (amino acids 241-290 of OR2C1) before application to your samples. Specific staining should be abolished or significantly reduced, as demonstrated in Western blot analysis of RAW264.7 cell lysates and immunofluorescence studies of A549 cells .

• Knockout/knockdown validation: Compare staining in wild-type versus OR2C1 knockout or knockdown samples.

• Cross-reactivity assessment: Test for possible cross-reactivity with closely related olfactory receptors, particularly OR2C2P, which is noted as a synonym in some databases .

• Multiple antibody approach: Use antibodies targeting different epitopes of OR2C1 to confirm staining patterns.

• Multiple detection methods: Confirm findings using complementary techniques (WB, IF, ICC) to build confidence in antibody specificity .

• Mass spectrometry verification: For ultimate confirmation, perform immunoprecipitation followed by mass spectrometry analysis.

How can researchers optimize immunofluorescence protocols specifically for OR2C1 detection in neural tissues?

Optimizing immunofluorescence protocols for OR2C1 detection in neural tissues requires special considerations:

• Fixation method: Use 4% paraformaldehyde for 15-20 minutes for cell cultures, or 24 hours for tissue sections. Avoid over-fixation which can mask epitopes of transmembrane proteins like OR2C1.

• Epitope retrieval: Since OR2C1 is a multi-pass membrane protein , heat-induced epitope retrieval (HIER) in citrate buffer (pH 6.0) may improve antibody accessibility to the 241-290 amino acid region .

• Permeabilization: Use 0.1-0.3% Triton X-100 for sufficient permeabilization of the cell membrane to access this GPCR.

• Blocking: Extended blocking (2 hours at room temperature or overnight at 4°C) with 5-10% normal serum from the same species as the secondary antibody plus 1% BSA helps reduce background.

• Antibody concentration: Start with a 1:200 dilution for OR2C1 antibody and optimize from there. Incubate overnight at 4°C for best results.

• Signal amplification: Consider tyramide signal amplification for detecting low abundance expression.

• Co-localization studies: Pair OR2C1 antibodies with markers for olfactory neurons (OMP) or GPCR trafficking machinery to gain functional insights.

• Confocal microscopy settings: Use appropriate filter settings and sequential scanning to prevent bleed-through when performing co-localization studies.

What are the recommended strategies for troubleshooting non-specific binding in Western blots using OR2C1 antibodies?

When encountering non-specific binding in Western blots with OR2C1 antibodies, systematically address these issues:

• Optimize antibody dilution: Begin with the manufacturer's recommended range (1:500-1:2000) and adjust as needed. Titrate to find the optimal signal-to-noise ratio.

• Blocking optimization: Test different blocking agents (5% non-fat milk, 5% BSA, or commercial blocking buffers) as certain blockers may work better with this GPCR antibody.

• Membrane washing: Increase washing duration and volume (4-5 washes of 10 minutes each with 0.1% Tween-20 in TBS) to reduce background.

• Sample preparation: Since OR2C1 is a membrane protein , optimize protein extraction with appropriate detergents (1% Triton X-100 or 0.5% SDS) to solubilize the protein effectively.

• Denaturating conditions: Test different reducing agent concentrations and heating conditions (70°C vs. 95°C) to ensure proper protein denaturation without aggregation.

• Expected molecular weight verification: OR2C1 has a molecular weight of approximately 34 kDa . Verify that your band of interest aligns with this expected size.

• Peptide competition: Run parallel blots with and without peptide competition using the immunizing peptide (241-290 amino acid region) to distinguish specific from non-specific bands.

• Gradient gels: Use 4-12% gradient gels to achieve better separation of proteins in the 25-40 kDa range where OR2C1 migrates.

• Alternative secondary antibodies: Test different secondary antibodies if non-specific binding persists.

How do OR2C1 antibodies perform in studies investigating olfactory signal transduction pathways?

OR2C1 antibodies have proven valuable for investigating olfactory signal transduction pathways through several experimental approaches:

• Pathway mapping: OR2C1 functions within the olfactory signaling and GPCR downstream signaling pathways . Antibodies enable researchers to track OR2C1's role in these pathways through co-immunoprecipitation with G proteins and adenylyl cyclase.

• Odorant specificity studies: OR2C1 specifically binds organosulfur odorants with thioether groups like (methylthio)methanetiol (MTMT), as well as acetophenone and benzaldehyde . Antibodies can be used in binding studies to elucidate structural determinants of odorant recognition.

• Receptor trafficking: Immunofluorescence with OR2C1 antibodies allows visualization of receptor trafficking between cellular compartments in response to odorant exposure.

• Receptor phosphorylation: Phospho-specific OR2C1 antibodies (custom-developed) can help track the activation state of the receptor after odorant binding.

• Developmental studies: As OR2C1 may be involved in the "fasciculation and targeting of olfactory axons" , antibodies can track its expression during critical developmental windows.

• Neuronal connectivity: When combined with tracers or other neural markers, OR2C1 antibodies help map the connectivity of specific olfactory sensory neurons to glomeruli in the olfactory bulb.

The antibody's validated applications in Western blot, immunofluorescence, and ELISA make it versatile for multiple experimental approaches in olfactory signaling research.

What considerations should be made when selecting OR2C1 antibody conjugates for multicolor flow cytometry or imaging?

When selecting OR2C1 antibody conjugates for multicolor experiments, consider these technical factors:

• Expression level considerations: OR2C1 may have relatively low expression in some cell types, so select brighter fluorophores (PE, APC, or Alexa Fluor 488) for direct detection .

• Spectral compatibility: When designing multicolor panels, consider these combinations:

  • For flow cytometry: OR2C1-PE pairs well with CD markers conjugated to APC, FITC, and BV421

  • For imaging: OR2C1-Alexa Fluor 594 works well with DAPI (nuclei) and Alexa Fluor 488 (other cellular structures)

• Available conjugates: Custom conjugation services are available for OR2C1 antibodies with various labels including:

  • Fluorescent dyes: Alexa Fluor series (AF350-AF750), iFluor series (350-860), mFluor series (UV375-Red780)

  • Enzymes: HRP, Alkaline Phosphatase

  • Tandem dyes: PE/Cy5, PE/Cy7, APC/Cy7

  • Small molecules: Biotin

• Signal amplification: For low-abundance OR2C1 detection, consider:

  • Primary antibody + fluorophore-conjugated secondary

  • Biotin-streptavidin systems

  • Tyramide signal amplification (TSA)

• Membrane protein considerations: As OR2C1 is a multi-pass membrane protein , certain conjugations may affect antibody binding to the 241-290 epitope region . Test smaller fluorophores if steric hindrance is suspected.

• Controls for specificity: Include FMO (fluorescence minus one) controls and isotype controls conjugated to the same fluorophore to confirm specificity in multicolor panels.

What are the key differences in sample preparation when using OR2C1 antibodies across different applications?

Sample preparation requirements vary significantly across applications:

For Western Blot:

• Tissue Extraction: For olfactory epithelium or neural tissues, use RIPA buffer supplemented with 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS.

• Membrane Protein Considerations: As OR2C1 is a transmembrane protein , include membrane solubilization steps. Sonicate samples 3-5 times in 10-second bursts with cooling between.

• Protein Denaturation: Heat samples at 70°C (not 95°C) for 5 minutes to avoid aggregation of this GPCR.

• Loading Control Selection: Use Na⁺/K⁺-ATPase or another membrane protein as a loading control rather than typical cytosolic proteins like GAPDH.

For Immunofluorescence:

• Fixation: Use 4% paraformaldehyde for 15 minutes at room temperature.

• Permeabilization: For this multi-pass membrane protein , use 0.2% Triton X-100 for 10 minutes.

• Antigen Retrieval: Perform citrate buffer (pH 6.0) heat-mediated antigen retrieval for tissue sections.

• Blocking: Block with 10% normal serum (from secondary antibody species) plus 1% BSA for 1 hour.

For ELISA:

• Coating Buffer: Use carbonate/bicarbonate buffer (pH 9.6) for plate coating.

• Sample Dilution: Prepare samples in diluent containing 1% BSA in PBS with 0.05% Tween-20.

• Standard Curve: Include recombinant OR2C1 protein at known concentrations (0.1-1000 ng/ml) for quantification.

• Incubation Time: Extend primary antibody incubation to overnight at 4°C at dilutions around 1:20000 .

For Immunoprecipitation:

• Cell Lysis: Use gentler NP-40 buffer (1% NP-40, 150 mM NaCl, 50 mM Tris pH 8.0) with protease inhibitors.

• Antibody Binding: Pre-bind 2-5 μg of OR2C1 antibody to Protein A/G beads before adding to lysates.

• Incubation: Extend incubation to overnight at 4°C with gentle rotation.

• Elution: Use mild elution conditions (0.1 M glycine, pH 3.0) to preserve protein-protein interactions.

How can researchers effectively compare data generated using different OR2C1 antibody clones or from different vendors?

When comparing data from different OR2C1 antibody sources, implement these methodological approaches:

• Epitope mapping comparison:

  • Document the target epitope regions for each antibody (e.g., amino acids 241-290)

  • Create an epitope map to visualize overlapping or distinct binding regions

  • Interpret discrepancies in results based on structural accessibility of different epitopes

• Standardized validation protocol:

  • Run identical positive controls (e.g., olfactory epithelium samples) with each antibody

  • Include a peptide competition control for each antibody

  • Process all samples simultaneously with standardized protocols

• Quantitative comparison:

  • For Western blots: Quantify band intensities and normalize to loading controls

  • For IF: Use standardized exposure settings and quantify fluorescence intensity

  • For ELISA: Create standard curves using recombinant OR2C1 protein

• Side-by-side comparison table:

What are the most effective methods for quantifying OR2C1 expression levels in different tissue types?

For accurate quantification of OR2C1 expression across tissue types, several complementary methods should be employed:

• qRT-PCR analysis:

  • Design primers spanning exon-exon junctions specific to OR2C1

  • Normalize to multiple reference genes appropriate for the tissue type

  • Include efficiency curves for accurate quantification

  • Useful for initial screening of multiple tissue types

• Western blot quantification:

  • Use graduated loading of recombinant OR2C1 protein to create a standard curve

  • Run multiple technical replicates (n≥3)

  • Quantify band intensity using software like ImageJ

  • Normalize to membrane protein loading controls

  • Recommended dilution range: 1:500-1:2000

• Quantitative immunofluorescence:

  • Apply standardized staining protocols across all tissues

  • Include calibration beads to normalize fluorescence intensity

  • Use automated image analysis software for unbiased quantification

  • Calculate the percentage of OR2C1-positive cells and mean fluorescence intensity

  • Recommended dilution range: 1:100-1:500

• ELISA-based quantification:

  • Develop a sandwich ELISA using two antibodies recognizing different OR2C1 epitopes

  • Generate a standard curve using recombinant OR2C1 protein

  • Validate with spike-and-recovery experiments

  • High sensitivity with typical dilutions around 1:20000

• Flow cytometry:

  • Particularly useful for single-cell analysis in dissociated tissues

  • Use appropriate permeabilization protocols for this membrane protein

  • Quantify using median fluorescence intensity (MFI)

  • Include fluorescence-minus-one (FMO) controls

• Mass spectrometry-based quantification:

  • Use targeted approaches like selected reaction monitoring (SRM)

  • Include heavy-labeled peptide standards corresponding to the OR2C1 sequence

  • Particularly useful for absolute quantification of protein levels

• In situ hybridization:

  • Complements antibody-based methods with mRNA detection

  • RNAscope technology provides single-molecule sensitivity

  • Allows spatial mapping of expression within complex tissues

For the most robust analysis, combine at least two orthogonal methods (e.g., qRT-PCR + Western blot) to confirm expression findings.

How can OR2C1 antibodies be used to study receptor trafficking and internalization dynamics?

OR2C1 antibodies can be powerful tools for investigating receptor trafficking dynamics through these methodological approaches:

• Live-cell antibody feeding assays:

  • Label OR2C1 antibodies with pH-sensitive fluorophores (pHrodo)

  • Apply to live cells expressing OR2C1

  • Track internalization through fluorescence changes as receptors move to acidic endosomes

  • Particularly useful for monitoring odorant-induced internalization

• Pulse-chase immunofluorescence:

  • Label surface OR2C1 at 4°C (prevents internalization)

  • Warm cells to 37°C to permit trafficking

  • Fix at different time points to create a temporal map of receptor movement

  • Use antibody conjugates or secondary antibodies with distinct fluorophores

• Co-localization studies:

  • Pair OR2C1 antibodies (dilution 1:100-1:500) with markers for:

    • Early endosomes (EEA1)

    • Recycling endosomes (Rab11)

    • Late endosomes/lysosomes (LAMP1)

    • ER (calnexin) and Golgi (GM130)

  • Calculate Pearson's correlation coefficients for quantitative assessment

• Surface biotinylation assays:

  • Biotinylate surface proteins

  • Allow internalization under various conditions (basal vs. odorant-stimulated)

  • Cleave remaining surface biotin

  • Immunoprecipitate OR2C1 and blot for biotin to quantify internalized fraction

• TIRF microscopy:

  • Visualize OR2C1 specifically at the plasma membrane

  • Track individual receptor clusters in real-time

  • Particularly powerful when combined with photoactivatable OR2C1 fusion proteins

• Antibody-based ELISA for surface expression:

  • Use non-permeabilizing conditions to quantify surface OR2C1

  • Compare to total OR2C1 levels in permeabilized cells

  • Calculate surface/total ratios under various treatments

• Endocytic blocker studies:

  • Combine OR2C1 antibodies with inhibitors of different endocytic pathways:

    • Dynamin inhibitors (dynasore)

    • Clathrin inhibitors (Pitstop-2)

    • Caveolae disruptors (nystatin)

  • Determine the predominant internalization mechanism

These techniques provide complementary data on the spatial and temporal dynamics of OR2C1 trafficking, particularly relevant given its role in olfactory signal transduction .

What controls and validation steps are essential when investigating OR2C1 post-translational modifications?

When studying post-translational modifications (PTMs) of OR2C1, implement these essential controls and validation steps:

• Phosphorylation studies:

  • Positive controls: Treat cells with adenylyl cyclase activators (forskolin) to increase GPCR phosphorylation

  • Negative controls: Treat with phosphatase before immunoprecipitation

  • Validation approach: Use phospho-specific antibodies alongside general OR2C1 antibodies (1:500-1:2000 dilution)

  • Technical control: Include λ-phosphatase treatment of duplicate samples

  • Confirmation method: Mass spectrometry to identify specific phosphorylation sites

• Glycosylation analysis:

  • Enzymatic controls: Treat samples with PNGase F or Endo H

  • Migration controls: Compare OR2C1 molecular weight before/after deglycosylation (expect reduction from observed weight toward the theoretical 34 kDa)

  • Validation approach: Use lectin binding to confirm glycosylation

  • Specificity control: Use tunicamycin to block N-glycosylation in cell culture

  • Confirmation method: Glycoproteomic analysis

• Ubiquitination assessment:

  • System controls: Express His-tagged ubiquitin in cells

  • Negative controls: Use ubiquitination inhibitors (MG132)

  • Validation approach: Immunoprecipitate OR2C1 and blot for ubiquitin

  • Technical control: Include deubiquitinase inhibitors in lysis buffers

  • Confirmation method: Mass spectrometry to identify ubiquitination sites

• Palmitoylation studies:

  • Chemical controls: Treat with hydroxylamine to cleave thioester bonds

  • Metabolic labeling: Use 17-ODYA (palmitate analog) for click chemistry

  • Validation approach: Acyl-biotin exchange assay

  • Technical control: Compare wild-type OR2C1 with predicted palmitoylation site mutants

  • Confirmation method: Mass spectrometry with site-specific analysis

• General PTM validation framework:

  • Sample preparation: Use specialized buffers with appropriate inhibitors for each PTM

  • Antibody selection: Verify the epitope region (241-290) doesn't overlap with potential PTM sites

  • Multiple detection methods: Combine biochemical assays with imaging techniques

  • Physiological relevance: Correlate PTMs with functional outcomes (receptor activation, trafficking)

  • Time course analysis: Establish temporal patterns of modification

These rigorous controls ensure that identified PTMs are genuine and physiologically relevant to OR2C1 function in olfactory signaling pathways .

How can researchers effectively combine OR2C1 antibodies with other molecular tools for comprehensive olfactory receptor studies?

Integrating OR2C1 antibodies with complementary molecular tools creates powerful experimental paradigms for comprehensive olfactory receptor research:

• CRISPR/Cas9 genome editing + antibody validation:

  • Generate OR2C1 knockout cell lines or animal models

  • Use OR2C1 antibodies (1:500-1:2000 for WB, 1:100-1:500 for IF) to confirm knockout

  • Create epitope-tagged knockin models for antibody-independent detection

  • Perform rescue experiments with wild-type and mutant OR2C1 variants

• Single-cell RNA-seq + immunofluorescence:

  • Map OR2C1 transcript expression across olfactory neuron populations

  • Validate protein expression patterns using OR2C1 antibodies

  • Create spatial-transcriptomic overlays of OR2C1 expression domains

  • Identify co-expressed genes for pathway analysis

• Calcium imaging + immunocytochemistry:

  • Monitor neuronal responses to OR2C1-specific odorants (organosulfur compounds with thioether groups)

  • Post-imaging fixation and staining with OR2C1 antibodies

  • Correlate functional responses with receptor expression levels

  • Combine with odorant structure-activity relationship studies

• Optogenetic tools + receptor trafficking assays:

  • Express light-sensitive channels in OR2C1-positive neurons

  • Manipulate neuronal activity with light stimulation

  • Track changes in OR2C1 localization using antibodies

  • Monitor adaptive changes in receptor expression and trafficking

• Proximity labeling + antibody pull-down:

  • Express OR2C1 fused to BioID or APEX2

  • Identify proximal proteins through biotinylation

  • Validate interactions by co-immunoprecipitation with OR2C1 antibodies

  • Map the dynamic OR2C1 interactome under various conditions

• In vivo viral tracing + immunohistochemistry:

  • Inject retrograde tracers into olfactory bulb glomeruli

  • Perform OR2C1 immunostaining on olfactory epithelium

  • Identify projection patterns of OR2C1-expressing neurons

  • Correlate with functional responses to specific odorants

• Super-resolution microscopy + multiplexed antibody detection:

  • Apply OR2C1 antibodies using standardized protocols

  • Combine with markers for specific cellular compartments

  • Visualize nanoscale distribution patterns of this multi-pass membrane protein

  • Implement cyclic immunofluorescence for multiplexed detection

• Computational modeling + structural studies:

  • Generate 3D models of OR2C1 based on homology modeling

  • Validate predictions using antibodies against specific domains

  • Correlate structural features with odorant binding specificity

  • Design structure-based mutations for functional testing

This integrated approach allows researchers to connect OR2C1 expression with functional outcomes, protein interactions, and structural characteristics in the olfactory system.

How are OR2C1 antibodies being employed in studies exploring olfactory receptor expression in non-olfactory tissues?

Recent research has expanded beyond traditional olfactory tissues to investigate OR2C1 expression in unexpected locations:

• Methodological approaches:

  • Tissue screening: Systematic analysis using OR2C1 antibodies (dilution 1:100-1:500) across tissue microarrays

  • Validation strategy: Combining protein detection (antibodies) with mRNA analysis (RT-PCR, in situ hybridization)

  • Functional correlation: Pairing expression data with calcium imaging to confirm functionality

  • Specificity controls: Using peptide competition with the immunizing peptide (241-290 region) to confirm staining specificity in novel tissues

• Emerging tissue expression patterns:

  • Respiratory system: Beyond olfactory epithelium, OR2C1 expression has been detected in respiratory epithelium

  • Reproductive tissues: Preliminary evidence suggests expression in testicular tissue

  • Gastrointestinal tract: Expression in enteroendocrine cells may link chemosensation to digestive physiology

  • Skin: Evidence for expression in certain dermal cell populations

• Functional implications:

  • Chemosensory roles: OR2C1 may detect environmental chemicals or endogenous metabolites

  • Developmental processes: Potential roles in tissue patterning and cellular migration

  • Pathophysiological relevance: Altered expression in disease states suggests regulatory functions

  • Drug target potential: Non-olfactory expression opens possibilities for therapeutic targeting

• Technical challenges:

  • Low expression levels: Requiring sensitive detection methods with OR2C1 antibodies

  • Receptor trafficking: Different subcellular localization patterns in non-olfactory tissues

  • Co-receptor requirements: Variations in signaling machinery across tissue types

  • Tissue-specific PTMs: Different post-translational modification patterns affecting antibody binding

• Emerging applications:

  • Biomarker development: OR2C1 expression as a diagnostic or prognostic indicator

  • Cell-type identification: Using OR2C1 as a marker for specific cell populations

  • Drug screening: Targeting OR2C1 in non-olfactory tissues for therapeutic effects

  • Regenerative medicine: Understanding OR2C1's role in tissue development and homeostasis

These investigations are expanding our understanding of olfactory receptor biology beyond traditional sensory roles, with OR2C1 antibodies serving as crucial tools for this exploration.

What are the latest developments in custom OR2C1 antibody conjugations for advanced imaging and flow cytometry applications?

Recent advances in OR2C1 antibody conjugation technologies are expanding research capabilities:

• Next-generation fluorophore conjugations:

  • Far-red and near-infrared dyes: Conjugation with iFluor 700-860 series enables deeper tissue imaging with less autofluorescence

  • Quantum dot coupling: Provides exceptional photostability for long-term imaging

  • Photoactivatable fluorophores: Enable super-resolution microscopy of OR2C1 distribution

  • Fluorescence lifetime probes: Allow FLIM-FRET studies of OR2C1 interactions

• Multiplex imaging strategies:

  • DNA-barcoded antibodies: Enable highly multiplexed imaging (>40 targets) with cyclic immunofluorescence

  • Mass cytometry conjugates: Metal-tagged OR2C1 antibodies for CyTOF analysis

  • Exchange-PAINT compatible tags: For super-resolution imaging of OR2C1 at nanoscale resolution

  • Spectral unmixing approaches: Using spectrally similar fluorophores with computational separation

• Functional imaging conjugates:

  • Calcium sensor fusion antibodies: Directly monitor activity near OR2C1 receptors

  • pH-sensitive dyes: Track OR2C1 internalization through endosomal compartments

  • FRET pairs: Monitor conformational changes or protein-protein interactions

  • Photoconvertible proteins: For pulse-chase studies of receptor trafficking

• Multi-modality imaging applications:

  • PET/SPECT compatible chelators: For in vivo imaging of OR2C1 expression

  • MRI contrast agent conjugations: For high-resolution anatomical correlation

  • Raman scattering tags: Label-free detection with high multiplexing capacity

  • Correlative light and electron microscopy (CLEM): Combining IF with ultrastructural analysis

• Custom conjugation services:

  • Diverse label options including:

    • AF (AF350-AF750)

    • iFluor (350-860)

    • mFluor (UV375-Red780)

    • Enzymes (HRP, Alkaline Phosphatase)

    • Protein tags (Biotin, Streptavidin)

    • Tandem dyes (PE/Cy5, PE/Cy7, APC/Cy7)

• Application-specific optimization:

  • Flow cytometry panels: Optimized tandem dye conjugates for minimal spectral overlap

  • Intravital microscopy: Stable, bright conjugates for in vivo imaging

  • High-content screening: Conjugates optimized for automated analysis platforms

  • Super-resolution microscopy: Photoswitchable dye conjugations for STORM/PALM imaging

These advanced conjugation technologies are expanding the utility of OR2C1 antibodies beyond traditional applications, enabling researchers to address increasingly sophisticated questions about olfactory receptor biology.

How might synthetic antibody technologies advance OR2C1 research beyond traditional polyclonal approaches?

Emerging synthetic antibody technologies offer promising advantages for advancing OR2C1 research:

• Single-domain antibodies (nanobodies):

  • Size advantage: At ~15 kDa versus 150 kDa for conventional antibodies, nanobodies can access restricted epitopes on this multi-pass membrane protein

  • Stability benefits: Greater resistance to pH and temperature extremes

  • Epitope accessibility: Potential to recognize conformational epitopes beyond the standard 241-290 region

  • Research applications: Super-resolution microscopy, in vivo imaging, and conformation-specific detection

• Recombinant antibody fragments:

  • Defined specificity: Precisely engineered binding to specific OR2C1 domains

  • Reproducibility: Elimination of batch-to-batch variation seen with polyclonal antibodies

  • Customization: Addition of fusion tags without affecting binding properties

  • Application potential: Standardized detection across research laboratories

• DNA-encoded antibody libraries:

  • High-throughput selection: Rapid identification of OR2C1-specific binders

  • Diverse epitope recognition: Coverage of multiple regions beyond the typical 241-290 segment

  • Affinity maturation: Engineering of higher-affinity variants for improved sensitivity

  • Research value: Detection of low-abundance OR2C1 expression in non-olfactory tissues

• Synthetic protein scaffolds:

  • Alternative binding molecules: DARPins, Affibodies, and Monobodies with high specificity

  • Rational design: Structure-based engineering for optimal binding

  • Modular functions: Addition of reporter or effector domains

  • Potential applications: Intracellular expression for live-cell tracking of OR2C1

• Aptamer technologies:

  • Non-protein recognition: DNA/RNA aptamers for specific OR2C1 binding

  • Chemical stability: Greater resistance to degradation in complex environments

  • Simple modification: Easy incorporation of fluorophores or functional groups

  • Research opportunities: Complementary approach to protein-based detection

• Computationally designed antibodies:

  • Structure-guided engineering: Design based on OR2C1 structural predictions

  • Epitope targeting: Precise selection of functionally relevant regions

  • Cross-species reactivity: Engineered conservation or species-specificity

  • Research impact: Consistent reagents for comparative studies across model organisms

These technologies promise to address current limitations of traditional polyclonal OR2C1 antibodies, particularly in terms of batch consistency, epitope accessibility in this multi-pass membrane protein , and specialized research applications.

What future experimental systems might benefit from combining OR2C1 antibodies with emerging technologies like organ-on-chip or spatial transcriptomics?

Integration of OR2C1 antibodies with cutting-edge technologies will enable novel experimental paradigms:

• Olfactory epithelium-on-chip systems:

  • Microfluidic platforms: Recreate nasal airflow over olfactory sensory neurons

  • Antibody applications: Real-time tracking of OR2C1 localization during odorant exposure

  • Integration potential: Combine with electrophysiology for structure-function correlation

  • Future directions: Personalized medicine applications for olfactory disorders

• Brain organoid models:

  • 3D neural systems: Generate olfactory bulb-like structures in vitro

  • Antibody utilization: Track OR2C1-expressing neurons during development

  • Technical approach: Whole-mount immunofluorescence with clearing techniques

  • Research prospects: Model genetic disorders affecting olfactory development

• Spatial transcriptomics integration:

  • Multi-omic correlation: Link OR2C1 protein expression (via antibodies) with local transcriptome

  • Technical implementation: Sequential immunofluorescence and in situ sequencing

  • Analytical power: Map OR2C1 protein levels against expression of interacting partners

  • Future applications: Comprehensive cellular atlas of olfactory system development

• Advanced tissue clearing + antibody penetration:

  • Whole-organ imaging: Visualize complete distribution of OR2C1 in intact olfactory systems

  • Technical requirements: Optimized penetration of OR2C1 antibodies in cleared tissues

  • Methodological approach: Adapt CLARITY, CUBIC, or iDISCO protocols for OR2C1 detection

  • Research impact: 3D mapping of olfactory receptor zonation and projections

• Digital spatial profiling platforms:

  • High-plex protein analysis: Measure OR2C1 alongside hundreds of other proteins

  • Antibody requirements: Validated OR2C1 antibodies compatible with multiplexed systems

  • Technical implementation: Antibody panels including OR2C1 for spatial proteomics

  • Research applications: Comprehensive protein networks in olfactory signal transduction

• Live-cell sensing technologies:

  • Antibody-based biosensors: Engineer OR2C1 conformational sensors

  • Technical design: FRET-based reporters using OR2C1 antibody fragments

  • Application potential: Real-time monitoring of receptor activation

  • Future integration: Combine with microfluidic odorant delivery systems

• Single-cell proteomics approaches:

  • Cellular heterogeneity: Quantify OR2C1 variations across individual cells

  • Technical methods: Mass cytometry or microfluidic western blot systems

  • Antibody requirements: Highly specific OR2C1 antibodies with minimal cross-reactivity

  • Research value: Define distinct cellular phenotypes based on OR2C1 expression levels

These emerging experimental systems, combined with validated OR2C1 antibodies (1:100-1:500 for imaging applications) , will enable unprecedented insights into the functional organization of olfactory systems at molecular, cellular, and tissue scales.